Cargando…

Peripheral blood cell‐free DNA is an alternative tumor DNA source reflecting disease status in myelodysplastic syndromes

Genetic alterations in myelodysplastic syndromes (MDS) are critical for pathogenesis. We previously showed that peripheral blood cell‐free DNA (PBcfDNA) may be more sensitive for genetic/epigenetic analyses than whole bone marrow (BM) cells and mononuclear cells in peripheral blood (PB). Here we ana...

Descripción completa

Detalles Bibliográficos
Autores principales:	Suzuki, Yasuhiro, Tomita, Akihiro, Nakamura, Fumika, Iriyama, Chisako, Shirahata‐Adachi, Mizuho, Shimada, Kazuyuki, Akashi, Akimi, Ishikawa, Yuichi, Kaneda, Norio, Kiyoi, Hitoshi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2016
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5021037/ https://www.ncbi.nlm.nih.gov/pubmed/27323954 http://dx.doi.org/10.1111/cas.12994

Ejemplares similares

De novo diffuse large B-cell lymphoma with a CD20 immunohistochemistry-positive and flow cytometry-negative phenotype: Molecular mechanisms and correlation with rituximab sensitivity
por: Tokunaga, Takashi, et al.
Publicado: (2014)

Pyruvate secreted from patient‐derived cancer‐associated fibroblasts supports survival of primary lymphoma cells
por: Sakamoto, Akihiko, et al.
Publicado: (2018)

Co-expression of wild-type FLT3 attenuates the inhibitory effect of FLT3 inhibitor on FLT3 mutated leukemia cells
por: Chen, Fangli, et al.
Publicado: (2016)

Emetine elicits apoptosis of intractable B-cell lymphoma cells with MYC rearrangement through inhibition of glycolytic metabolism
por: Aoki, Tomohiro, et al.
Publicado: (2016)

Identification of volasertib-resistant mechanism and evaluation of combination effects with volasertib and other agents on acute myeloid leukemia
por: Adachi, Yoshiya, et al.
Publicado: (2017)

Identification of the novel deletion-type PML-RARA mutation associated with the retinoic acid resistance in acute promyelocytic leukemia
por: Hattori, Hikaru, et al.
Publicado: (2018)

Current progress and future perspectives of research on intravascular large B‐cell lymphoma
por: Shimada, Kazuyuki, et al.
Publicado: (2021)

Clinical significance of nuclear non-phosphorylated beta-catenin in acute myeloid leukaemia and myelodysplastic syndrome
por: Xu, Jinglan, et al.
Publicado: (2008)

Discovery of a drug targeting microenvironmental support for lymphoma cells by screening using patient-derived xenograft cells
por: Sugimoto, Keiki, et al.
Publicado: (2015)

SPIB is a novel prognostic factor in diffuse large B‐cell lymphoma that mediates apoptosis via the PI3K‐AKT pathway
por: Takagi, Yusuke, et al.
Publicado: (2016)

Detection of circulating tumor DNA in cerebrospinal fluid prior to diagnosis of spinal cord lymphoma by flow cytometric and cytologic analyses
por: Iriyama, Chisako, et al.
Publicado: (2021)

Phase I study of cord blood transplantation with intrabone marrow injection of mesenchymal stem cells: A clinical study protocol
por: Goto, Tatsunori, et al.
Publicado: (2018)

FLT3 mutations in acute myeloid leukemia: Therapeutic paradigm beyond inhibitor development
por: Kiyoi, Hitoshi, et al.
Publicado: (2019)

Comparison of clonal architecture between primary and immunodeficient mouse-engrafted acute myeloid leukemia cells
por: Kawashima, Naomi, et al.
Publicado: (2022)

Influence of DNA methylation on positioning and DNA flexibility of nucleosomes with pericentric satellite DNA
por: Osakabe, Akihisa, et al.
Publicado: (2015)

Clinical utility of target capture‐based panel sequencing in hematological malignancies: A multicenter feasibility study
por: Yasuda, Takahiko, et al.
Publicado: (2020)

Characterization of Serous Cell-Free DNA in Myelodysplastic Syndromes
por: Zhu, Hongbo, et al.
Publicado: (2022)

Phase II study of intrabone single unit cord blood transplantation for hematological malignancies
por: Murata, Makoto, et al.
Publicado: (2017)

Using circulating tumor DNA to monitor myelodysplastic syndromes status
por: Zhao, Pan, et al.
Publicado: (2019)

Molecular and cytogenetic characterization of myelodysplastic syndromes in cell-free DNA
por: Garcia-Gisbert, Nieves, et al.
Publicado: (2022)

Azacitidine regulates DNA methylation of GADD45γ in myelodysplastic syndromes
por: Yang, Yanli, et al.
Publicado: (2020)

Reflections on my daughter's DNA
por: Rienhoff, Hugh Young
Publicado: (2016)

Machine learning-aided risk stratification in Philadelphia chromosome-positive acute lymphoblastic leukemia
por: Nishiwaki, Satoshi, et al.
Publicado: (2021)

Mutation and apoptosis are well-coordinated for protecting against DNA damage-inducing toxicity in Drosophila
por: Toyoshima-Sasatani, Megumi, et al.
Publicado: (2023)

DNA Methylation Changes Following 5-azacitidine Treatment in Patients with Myelodysplastic Syndrome
por: Tran, Huong Thi Thanh, et al.
Publicado: (2011)

Potential Relationship between Inadequate Response to DNA Damage and Development of Myelodysplastic Syndrome
por: Zhou, Ting, et al.
Publicado: (2015)

Arsenic Disulfide Promoted Hypomethylation by Increasing DNA Methyltransferases Expression in Myelodysplastic Syndrome
por: Zhou, Qing-Bing, et al.
Publicado: (2020)

TET2 mutations as a part of DNA dioxygenase deficiency in myelodysplastic syndromes
por: Gurnari, Carmelo, et al.
Publicado: (2022)

The Dawn of next generation DNA sequencing in myelodysplastic syndromes- experience from Pakistan
por: Anwar, Nida, et al.
Publicado: (2021)

Whole-Genome DNA Methylation Sequencing Reveals Epigenetic Changes in Myelodysplastic Syndromes
por: Zhou, Jing-dong, et al.
Publicado: (2022)

Comparative analysis of TTF‐1 binding DNA regions in small‐cell lung cancer and non‐small‐cell lung cancer
por: Hokari, Satoshi, et al.
Publicado: (2019)

Allogeneic hematopoietic stem cell transplantation at the first remission for younger adults with FLT3‐internal tandem duplication AML: The JALSG AML209‐FLT3‐SCT study
por: Kawashima, Naomi, et al.
Publicado: (2020)

Utility of cerebrospinal fluid liquid biopsy in distinguishing CNS lymphoma from cerebrospinal infectious/demyelinating diseases
por: Iriyama, Chisako, et al.
Publicado: (2023)

DNA Methylation Events as Markers for Diagnosis and Management of Acute Myeloid Leukemia and Myelodysplastic Syndrome
por: Dexheimer, Geórgia Muccillo, et al.
Publicado: (2017)

Mutations in genes affecting DNA methylation enhances responses to decitabine in patients with myelodysplastic syndrome
por: Jung, Hyun Ae, et al.
Publicado: (2021)

DNA Methylation Is Correlated with Oxidative Stress in Myelodysplastic Syndrome—Relevance as Complementary Prognostic Biomarkers
por: Gonçalves, Ana Cristina, et al.
Publicado: (2021)

Functional polymorphisms of DNA repair genes in Latin America reinforces the heterogeneity of Myelodysplastic Syndrome
por: Borges, Daniela de Paula, et al.
Publicado: (2023)

Array-based comparative genomic hybridization for genomic-wide screening of DNA copy number alterations in aggressive bone tumors
por: Kanamori, Masahiko, et al.
Publicado: (2012)

A superelderly case of TAFRO syndrome treated effectively using corticosteroid hormones
por: Shimada, Yoshitaka, et al.
Publicado: (2018)

Phase I clinical trial of intra‐bone marrow cotransplantation of mesenchymal stem cells in cord blood transplantation
por: Goto, Tatsunori, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_fub1vh08hrv3uuqd3q8nggehka